Man Group PLC Immunity Bio, Inc. Transaction History

Man Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.53 - $6.41 $15,670 - $65,651	10,242 New	10,242 $28,000
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $37,960 - $66,872	10,400 Added 85.25%	22,600 $112,000
Q2 2022 Aug 15, 2022	SELL	$2.68 - $6.14 $30,200 - $69,191	-11,269 Reduced 48.02%	12,200 $45,000
Q1 2022 May 16, 2022	BUY	$5.05 - $7.53 $118,518 - $176,721	23,469 New	23,469 $132,000

202

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.